•  3
    Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
    with B. M. Ellingson, M. Bendszus, J. Boxerman, D. Barboriak, B. J. Erickson, M. Smits, S. J. Nelson, E. Gerstner, B. Alexander, G. Goldmacher, W. Wick, M. Vogelbaum, M. Weller, E. Galanis, J. Kalpathy-Cramer, L. Shankar, P. Jacobs, W. B. Pope, D. Yang, C. Chung, M. V. Knopp, S. Cha, M. J. Van Den Bent, S. Chang, Al Yung W. K., T. F. Cloughesy, P. Y. Wen, A. Whitney, D. Sandak, A. Musella, C. Haynes, M. Wallace, D. F. Arons, and A. Kingston
    © 2015 The Author.A recent joint meeting was held on January 30, 2014, with the US Food and Drug Administration, National Cancer Institute, clinical scientists, imaging experts, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocate groups to discuss imaging endpoints for clinical trials in glioblastoma. This workshop developed a set of priorities and action items including the creation of a standardized MRI protocol for multicenter studies. The current do…Read more